Clinical Trials Directory

Trials / Completed

CompletedNCT06113796

Economic Analysis of Robotic Rectal Resection in German Health Care System

Status
Completed
Phase
Study type
Observational
Enrollment
65 (actual)
Sponsor
Universitätsklinikum Hamburg-Eppendorf · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Analysis of cost effectiveness of robotic rectal resection, either sphincter preserving or abdominoperineal extirpation, in the German diagnosis related groups (DRG) system.

Detailed description

Robotic surgery has many well-known benefits for patients and surgeons, while it comes with higher acquisition and maintenance costs. On the other hand, a higher proportion of minimally invasive procedures can save costs by reducing complications, decreasing hospital stays due to lower morbidity, and saving personnel. To what extent can robotic surgery be cost-covering or even profitable, depending on the postoperative course? This question is investigated under the conditions of the German DRG system.

Conditions

Interventions

TypeNameDescription
OTHERSurgeryRobotic rectal resection, either sphincter preserving or extirpation

Timeline

Start date
2018-01-01
Primary completion
2019-12-31
Completion
2021-12-31
First posted
2023-11-02
Last updated
2023-11-02

Locations

1 site across 1 country: Germany

Regulatory

Source: ClinicalTrials.gov record NCT06113796. Inclusion in this directory is not an endorsement.